T. Rowe Price Investment Management, Inc. 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | VAXCYTE INC PCVX | T. Rowe Price Investment Management, Inc. | 11,296,333 8.600% | 2,980,857 (+35.85%) | Filing |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | VAXCYTE INC PCVX | T. Rowe Price Investment Management, Inc. | 8,315,476 6.400% | 8,315,476 (New Position) | Filing |